REVIEW ON NOVEL OSMOTIC DRUG DELIVERY SYSTEM

  • AS Bansode Bhagwant University, Ajmer, Rajasthan, India- 305004
  • K Sarvanan Bhagwant University, Ajmer, Rajasthan, India- 305004
DOI https://doi.org/10.22270/jddt.v8i5-s.1961

Abstract

Novel drug delivery systems (NDDS) are the key area of pharmaceutical research and Development. The reason is relatively low development cost and time required for introducing a NDDS as compared to new chemical entity. Many conventional drug delivery systems have been designed to modulate the release a drug over an extended period of a time. Various designs are available to control or modulate the drug release from a dosage forms. Majority of oral CR dosage forms fall in the category of matrix, reservoir or osmotic systems. Osmotically controlled drug delivery systems (OCDDS) is one of the most promising drug delivery technology that use osmotic pressure as a driving force for controlled delivery of active agents. Drug release from OCDDS is independent of pH and hydrodynamic conditions of the body because of the semipermeable nature of the Rate controlling membrane and the design of deliver orifice used in osmotic systems, so a high degree of In vitro/In vivo correlation is achieved. Osmotic drug delivery systems release the drug with the zero order kinetics which does not depend on the initial concentration and the physiological factors of GIT. This review brings out new technologies, fabrication and recent clinical research in osmotic drug delivery.


Keywords: Osmotic, Matrix, Reservoir, Fabrication

Downloads

Download data is not yet available.

Author Biographies

AS Bansode, Bhagwant University, Ajmer, Rajasthan, India- 305004

Bhagwant University, Ajmer, Rajasthan, India- 305004

K Sarvanan, Bhagwant University, Ajmer, Rajasthan, India- 305004

Bhagwant University, Ajmer, Rajasthan, India- 305004

References

1. Madhavi BB, Nath AR, Banji D, Ramalingam R, Madhu MN, Kumar DS. Osmotic drug delivery system: a review. Pharmakine, dec 2009; 2:5-14.
2. Prescott, L.F, The need for improved drug delivery in clinical practice, in: Prescott LF, Nimmo W (eds), Novel Drug Delivery and Its Therapeutic Application, John Wiley, UK, pp 1–11, 1989.
3. Sastry SV, DeGennaro MD, Reddy IK, Khan MA. Atenolol gastrointestinal therapeutic system Part 1: Screening of formulation variables. Drug Dev Ind Pharm 1997; 23(2):157–165.
4. Mishra B,Makesh BK, Sankar C. Oral push-pull osmotic pumps of pentazocine hydrochloride: development and evaluation. Ind J Pharm Sci, 2006; 68(1):85-87.
5. Verma RK, Krishna DM, Garg S. Formulation aspects in the development of osmotically controlled oral drug delivery systems. J Control Release, 2002; 79:7–27
6. YANG Xing-Gang, ZHANG Guo-Hua, LI Wei, PENG Bo, LIU Zhi-Dong, PAN Wei-San. Design and Evaluation of Jingzhiguanxin Monolithic Osmotic Pump, Chem pharm bull, 2006; 54: 4: 465-469.
7. Kojima H, Yoshihara K, Sawada T, Kondo H, Sako K. PEO/polyethylene glycol (PEG) matrix tablets. Eur. J. Pharm. Biopharm, 2008; 70(2):556-562.
8. Aulton's Pharmaceutics; the Design and Manufacture of Medicines. 3rd ed. Philadelphia, USA: Churchill Livingstone Elsevier. pp: 99-102.)
9. Singh K, Walia MK, Aagrawal G, Harikumar SL. Osmotic pump drug delivery system: a noval approach, Journal of Drug Delivery & Therapeutics; 2013; 3(5):156-162.
10. Rose S, Nelson JF. A continuous long-term injector. Aust J Exp Biol, 1955; 33:415.
11. Higuchi T, Leeper HM. Improved osmotic dispenser employing magnesium sulfate and magnesium chloride. US Patent 3760804, 1973.
12. Higuchi T, Leeper HM. Osmotic dispenser with means for dispensing active agent responsive to osmotic gradient. US Patent 3995631, 1976.
13. Theeuwes, F. Elementary Osmotic Pump. J Pharm Sci, 1975; 64:1987-1991.
14. F. Theeuwes, Osmotic system for delivering selected beneficial agents having varying degrees of solubility, US Patent No. 4,111,201 (1978).
15. Gadwal P, Rudrawal P. International Journal of Pharmacy & Life Sciences 2010; 1(6):302-312.
16. Theeuwes, F. Elementary Osmotic Pump. J Pharm Sci, 1975; 64:1987-1991.
17. Kaushal AM, Garg S. An update on osmotic drug delivery patents. Pharm Tech, Aug 2003; 27:38-44.
18. Liu L, Ku J, Khang G, Lee B, Rhee JM, Lee HB. Nifedipine controlled delivery by sandwiched osmotic tablet system. J Control Release, 2000; 68:145–156.
19. Srenivasa B, Kumar NR, Murthy KVR. Eastern Pharmacist 2001; 22.
20. Haslem J, Rork GS. Controlled porosity osmotic pump. US Patent 488063, 1989.
21. Thombrea AG, Cardinall JR, DeNoto AR, HerbigSM, Smith KL. Asymmetric membrane capsules for osmotic drug delivery: Development of a manufacturing process. J Control Release, 1999; 57:55-64.
22. Zentner GM, Rork GS, Himmelsteine KJ. Osmotic flow through controlled porosity films: an approach to deliver water soluble compounds. J Control Release, 1985; 2:217-229.
23. Parmar NS, Vyas SK, jain NK. Advances in controlled and novel drug delivery. CBS publisher & distributors, New Delhi, pp 18-39, 2001.
24. Liu L, Ku J, Khang G, Lee B, Rhee JM, Lee HB. Nifedipine controlled delivery by sandwiched osmotic tablet system. J Control Release, 2000; 68:145–156.
25. Gadwal P, Rudrawal P. International Journal of Pharmacy & Life Sciences 2010; 1(6):302-312.
26. Sharma S, Singh SP, Bhardwaj S, Gaurave K, Gupta GD. Latest Reviews [Internet]. 2008; 6.
27. Rastogi SK, Vaya N, Mishra B. East Pharm 1995; 38:79-82.
28. Santus G., Baker RW. Controlled Release 1995; 35:1–2.
29. B Lindstedt, G Ragnarsson, J Hjartstam. Int J Pharm 1989; 56:261–268.
30. Seminoff, GM Zentner. Cellulosic coating, US patent 1992; 5:126-146.
31. Tanmoy Ghosh, Amitava Ghosh. Journal of Applied Pharmaceutical Science 2011; 1(2):38-49.
32. Sahoo C, Rao S, Sudhakar M. Formulation and evaluation of controlled porosity osmotic pump tablets for zidovudine and lamivudine combination using fructose as osmogen. Journal of Drug Delivery and Therapeutics, 2017; 7(4):41-50. https://doi.org/10.22270/jddt.v7i4.1465
Crossmark
Statistics
991 Views | 1176 Downloads
How to Cite
1.
Bansode A, Sarvanan K. REVIEW ON NOVEL OSMOTIC DRUG DELIVERY SYSTEM. JDDT [Internet]. 15Oct.2018 [cited 29Apr.2024];8(5-s):87-3. Available from: https://www.jddtonline.info/index.php/jddt/article/view/1961
Issue
Vol 8 No 5-s (2018)
Section
Review
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).